1.Clinical studies of liver cirrhosis with special reference to its etiology and prognosis.
Akihiko YUMINO ; Koichi YAMASHITA ; Shigefumi SHIMIZU ; Koji ISOMURA ; Shusuke NATSUKAWA ; Kazuyoshi ONISHI ; Shigenobu TERASHIMA ; Shinji SASAKI
Journal of the Japanese Association of Rural Medicine 1986;35(4):755-764
A total of 194 cases of liver cirrhosis, which had been treated in our hospital during the past 5 years, were calssified by the causes into the following four groups:(I) hepatitis B virus, (II) alcoholic, (III) special origins, and (IV) reasons unknown. They each accounted for 23.2%, 35.6%, 1.5% and 39.7%, of the total.
Their clinical features and prognosis were examined. To be noted is the finding that many patients in group IV had had blood transfusions. This suggests that non A non B hepatitis viruses might be involved in the occurrence of the liver disease. On the whole, the five-year survival rate was 45.6%. There was not any significant difference among the four groups. However, prognoses were poor in groups II, I and IV, in that order.
As regards the cause of death, rupture of esophageal varice and hepatic failure showed a gradual decline, but complications of hepatocellular carcinomas sharply increased. Especially, in group I, this mortality was as high as 31.1%.
2.Clinical Characteristics of Chronic Otolaryngeal Patients Treated with Kampo Medicines
Hitoshi NISHIKAWA ; Shin TAKAYAMA ; Akiko KIKUCHI ; Takehiro NUMATA ; Yuka IKENO ; Soichiro KANEKO ; Tetsuharu KAMIYA ; Ryutaro ARITA ; Natsumi SAITO ; Minoru OHSAWA ; Michiyo KOJIMA ; Hiroyo SASAKI ; Kazuyoshi YAMASHITA ; Tadashi ISHII
Kampo Medicine 2019;70(1):18-24
The background and course of Kampo treatment in 39 patients with uncontrollable otolaryngeal symptoms treated between April 2013 and March 2016, in the Department of Kampo Medicine at Tohoku University Hospital, were analyzed retrospectively. An improvement in overall symptoms was noted with Kampo treatment in 28 of 39 cases (71%). The commonly reported subjective symptoms included glossodynia (7 cases), postnasal drip (4 cases), oral discomfort (4 cases), dizziness (3 cases), and taste disorder (3 cases). Analysis using the classification of qi, blood, and fluid revealed that cases with qi stagnation pattern (15 of 18 cases) were effectively treated with Kampo treatment. Prior reports support our finding that smoothing qi with Kampo medicine is effective in alleviating some chronic symptoms. The symptoms improved within 6 weeks after the treatment was initiated. Therefore, a 6-week period can be considered sufficient to determine the effectiveness of Kampo medicine. Many of the patients for whom Kampo treatment was not effective had depression and domestic stress. In conclusion, Kampo treatment may be effectively used to treat uncontrollable, chronic otolaryngeal symptoms in selected cases that are unresponsive to Western medicine.